Quick Answer
Regulation M-A is a 1999 SEC rule-set that standardized M&A disclosure across forms by collecting common items (summary term sheet, subject company information, terms of the transaction, financial statements, fairness opinions, exhibits) into a single numbered framework. The items are pulled into Schedule TO, Schedule 14D-9, Schedule 13E-3, Form S-4, and Schedule 14A; the regulation is a disclosure OVERLAY, not a stand-alone filing.
Regulation M-A unifies M&A disclosure across the different SEC forms a banker will see. Knowing what items it contains and where they get incorporated is the recall component of this unit.
What Regulation M-A Does
Regulation M-A consolidated and standardized M&A disclosure across multiple forms:
- Applies to issuer and third-party tender offers, going-private transactions, and certain mergers
- The regulation is not a stand-alone form: its items are pulled into other filing documents
- The disclosure overlay covers the basics that any M&A filing should contain regardless of the specific deal structure
- The same Regulation M-A item appears in different forms with slightly different scope depending on the transaction type
Exam Tip: Gotchas
- Regulation M-A is a DISCLOSURE OVERLAY, not a stand-alone form. Its items are pulled into multiple forms (Schedule TO, Schedule 14D-9, Schedule 13E-3, Form S-4, and Schedule 14A Item 14). The Regulation M-A items themselves are not filed; the forms that incorporate them are.
- The same item can mean slightly different things in different forms. Item 1010 (financial statements), for example, has different applicability in a third-party tender offer (Schedule TO) versus an issuer tender offer (Schedule TO-I).
Regulation M-A Items
| Item | Topic |
|---|---|
| Item 1000 | Definitions |
| Item 1001 | Summary term sheet (plain-English bullet-point summary of material terms) |
| Item 1002 | Subject company information |
| Item 1003 | Identity and background of filing person |
| Item 1004 | Terms of the transaction |
| Item 1005 | Past contacts, transactions, negotiations, and agreements |
| Item 1006 | Purposes of the transaction and plans / proposals |
| Item 1007 | Source and amount of funds or other consideration |
| Item 1008 | Interests in securities of the subject company |
| Item 1009 | Persons / assets retained, employed, compensated, or used |
| Item 1010 | Financial statements |
| Item 1011 | Additional information |
| Item 1012 | Solicitation or recommendation |
| Item 1013 | Purposes, alternatives, reasons, and effects (going-private) |
| Item 1014 | Fairness of the transaction (going-private) |
| Item 1015 | Reports, opinions, appraisals, and negotiations |
| Item 1016 | Exhibits |
Exam Tip: Gotchas
- Item 1001 is the plain-English summary term sheet. Required in plain English, bullet-point format, at the front of the disclosure document. It is the one item every M&A disclosure starts with regardless of the underlying form.
- Items 1013 and 1014 are the going-private-specific items. They cover purpose, alternatives, reasons, effects, and fairness of the transaction; these items appear in Schedule 13E-3 but not in a standard third-party tender offer on Schedule TO.
Where the Items Get Used
Regulation M-A items are incorporated into a small set of M&A-specific forms and schedules:
- Schedule TO: third-party and issuer tender offers
- Schedule 14D-9: target's recommendation in a tender offer
- Schedule 13E-3: going-private transactions
- Schedule 14A: proxy statement, where the M&A-specific carve-out incorporates many Regulation M-A items
- Form S-4: business combination registration
Each form references the relevant Regulation M-A items by number. The overlay structure means a banker preparing a Schedule TO and a banker preparing a Form S-4 work from the same item taxonomy and produce similar disclosure even though the underlying forms have different primary purposes.
Exam Tip: Gotchas
- The same Regulation M-A item appears in multiple forms but with different scope. Item 1010 (financial statements) is required in some tender offers and not others; the form's specific instructions control.
- Schedule 13E-3 is the going-private form. It uses Regulation M-A items plus the going-private-specific items (Items 1013 and 1014). This is the form to remember when an issuer or affiliate is taking the company private and the going-private rule applies.
The Plain-English Summary Term Sheet
The summary term sheet item deserves separate attention because it is exam-tested across forms:
- Required in plain English, bullet-point format, at the front of the disclosure document
- Must briefly describe the most material terms: transaction structure, consideration, timing, conditions, and fees
- Applies to all cash tender offers, cash mergers, and going-private transactions
- The plain-English requirement reflects the SEC's broader plain-English initiative for disclosure documents
The summary term sheet exists because the underlying disclosure documents are long, dense, and technical; the SEC wants every shareholder to be able to read the first page and understand the deal in plain language before deciding whether to read further.
Think of it this way: the summary term sheet is the executive summary the SEC requires every M&A disclosure to put up front. It is the part a busy investor reads in 60 seconds; the rest of the disclosure is the supporting detail.
Exam Tip: Gotchas
- The summary term sheet must be in PLAIN ENGLISH. No legal jargon, no defined-term abbreviations the average reader cannot follow, and no run-on prose. The SEC has rejected disclosures that buried material terms in dense paragraphs.
- The summary term sheet must appear at the FRONT. It is the first substantive content the shareholder sees, not an appendix or schedule.